Bionic Sensing and Intelligence Center, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
Dr. Lin Zeng
Bionic Sensing and Intelligence Center, Institute of Biomedical and Health Engineering, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
The separation and purification of a sample of interest is essential for subsequent detection and analysis procedures, but there is a lack of effective separation methods with which to purify nano-sized particles from the sample media. In this paper, a microfluidic system based on negative magnetophoresis is presented for the high-resolution separation of nanoparticles. The system includes on-chip magnetic pole arrays and permalloys that symmetrically distribute on both sides of the separation channel and four permanent magnets that provide strong magnetic fields. The microfluidic system can separate 200 nm particles with a high purity from the mixture (1000 nm and 200 nm particles) due to a magnetic field gradient as high as 10,000 T/m being generated inside the separation channel, which can provide a negative magnetophoretic force of up to 10 pN to the 1000 nm particle. The overall recovery rate of the particles reaches 99%, the recovery rate of 200 nm particles is 84.2%, and the purity reaches 98.2%. Compared with the existing negative magnetophoretic separation methods, our system not only exhibits high resolution on particle sizes (800 nm), but also improves the sample processing throughput, which reaches 2.5 μL/min. The microfluidic system is expected to provide a new solution for the high-purity separation of nanoparticles, as well as nanobiological samples.
8 December 2025 in Journal of Extracellular Vesicles
Small Extracellular vesicles (sEVs) hold great promise as therapeutic delivery vehicles due to their inherent biocompatibility. However, their clinical translation is limited by donor cell source dependency and inadequate targeting capabilities. To overcome these challenges, we introduce a universal surface engineering strategy that integrates lipid membrane anchoring with targeted ligand conjugation. At the core of this approach is the sEV Surface‐Engineering microfluidic device (ExoSE), a dual‐functional platform combining nanofluidic and microfluidic architectures. ExoSE consists of two interconnected modules: (1) a loading module that employs mechanoporation via nanochannels to transiently generate pores in sEV membranes, enabling highly efficient insertion of functionalized lipids and (2) a mixing module with specialized structures that facilitate rapid, covalent attachment of targeting ligands via optimized chemical reactions. This approach achieved lipid incorporation efficiencies of 97.93% for HEK293T‐dervied sEVs and 98.47% for milk‐derived sEVs, surpassing conventional co‐incubation techniques. NanoFCM analysis revealed a 3‐ to 6‐fold increase in ligand binding per sEV. Functionally, RGE peptide‐modified sEVs exhibited a 54.13% increase in transmembrane transport efficiency in the in vitro model and enhanced infiltration into glioma spheroid, while AS1411 aptamer‐conjugated sEVs showed 77.8% targeting specificity towards breast cancer cells, compared to 32.5% for normal breast cells. In vivo tracking in BALB/c‐nude mice confirmed significantly improved brain accumulation of engineered sEVs, with no detectable hepatic or renal toxicity. Unlike traditional donor‐cell‐dependent genetic modification approaches, ExoSE enables universal, scalable modification of sEVs from diverse sources, including highly abundant milk‐derived sEVs, and accommodates diverse ligand types such as peptides, aptamers and proteins. This device represents a transformative advancement in sEV engineering, establishing a standardized and scalable framework for precision‐targeted sEV therapeutics with enhanced clinical potential.
A method for analyzing the influence of velocity changes on metal signals of different materials in oil detection technology is proposed. The flow rate of metal contaminants in the oil will have a certain impact on the sensitivity of the output particle signal in terms of electromagnetic fields and circuits. The detection velocity is not only related to the sensitivity of the output particle signal, but also to the adaptability of high-speed and high-throughput in oil online monitoring. In this paper, based on a high-sensitivity inductive bridge, the eddy current effect of velocity in a time-harmonic magnetic field is theoretically analyzed and experimentally verified, the phenomenon of particle signal variation with velocity for different materials is analyzed and discussed, and finally the effect of velocity on the output signal of the processing circuit is also elaborated and experimentally verified. Experiments show that under the influence of the time-harmonic magnetic field, the increase of the velocity enhances the detection sensitivity of non-ferromagnetic metal particles and weakens the detection sensitivity of non-ferromagnetic particles. Under the influence of the processing circuit, different velocities will produce different signal gains, which will affect the stability of the signal at different velocities.
The development of high-throughput technologies for the separation and labeling of extracellular vesicles (EVs) from whole blood is critical for downstream EV detection and analysis. However, conventional EV separation and labeling workflows are typically labor-intensive and inefficient, requiring multiple sequential processing steps. Here, we present a microfluidic platform that integrates negative magnetophoresis-based separation with mixing-enhanced on-chip labeling. The chip adopts a vertical flow channel architecture in combination with a Halbach-array magnetic field configuration, thereby overcoming the throughput limitations inherent to traditional horizontal microchannels. Parallel channels can be freely arranged above on the magnetic array to achieve ultra-high throughput processing, achieving a cell removal efficiency of 99.97% at a blood-to-sheath flow ratio of 1:5. Furthermore, by incorporating a narrow-wide channel design synergized with a herringbone–Tesla micromixer structure, the platform achieves a labeling efficiency of 91.8% within 2 min, approaching the performance of conventional 20 min incubation. This system offers both high-throughput and integration capabilities, providing a powerful technical platform for EV-related life science research.